Early outcome of combined thrombolysis based on the mismatch on perfusion CT

Cerebrovascular Diseases

Volumn 28, Issue 3, 2009, Pages 259-265

  Kim, Joon Tae ^a   Yoon, Woong ^a   Park, Man Seok ^a,c   Nam, Tai Seung ^a   Choi, Seong Min ^a,b   Lee, Seung Han ^a   Kim, Byeong Chae ^a   Kim, Myeong Kyu ^a   Cho, Ki Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Combined thrombolysis; Early outcome; Perfusion computed tomography; Recanalization

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; PERFUSION COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PERFUSION; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67650187923     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228256     Document Type: Article

References (27)

1. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, Ojemann RG: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773-782.
2. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC: Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000;31:1812-1816. (Pubitemid 30620455)
3. Humpich M, Singer OC, du Mesnil de Rochemont R, Foerch C, Lanfermann H, Neumann-Haefelin T: Effect of early and delayed recanalization on infarct pattern in proximal middle cerebral artery occlusion. Cerebrovasc Dis 2006;22:51-56.
4. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW: Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008;39:2257-2263.
5. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B: The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial. Circulation 1987;75:817-829. (Pubitemid 17052667)
6. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intraarterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
8. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European- Australasian acute stroke study investigators. Lancet 1998;352:1245-1251. (Pubitemid 28470336)
9. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083. (Pubitemid 36402991)
10. Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kanter D, Jauch E, Carrozzella J, Spilker J, Broderick J: Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000;31:2552-2557. (Pubitemid 30813043)
11. Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS 3rd, Cacayorin ED, Grotta JC, Noser EA: Is intra-arterial thrombolysis safe after fulldose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80-84.
12. Pannell R, Black J, Gurewich V: Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J Clin Invest 1988;81:853-859. (Pubitemid 18079736)
13. Lee KY, Kim DI, Kim SH, Lee SI, Chung HW, Shim YW, Kim SM, Heo JH: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470-1475. (Pubitemid 44383595)
14. Han MK, Kim SH, Ko SB, Paik NJ, Kwon OK, Lee YS, Oh CW, Kim JH, Park SH, Bae HJ: Combined intravenous and intraarterial revascularization therapy using MRI perfusion/ diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset. Neurocrit Care 2008;8:353-359.
15. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605.
16. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J: Combined intraarterial/ intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:352-358. (Pubitemid 32163468)
17. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-911. (Pubitemid 38419800)
18. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
19. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-mHz transcranial Doppler monitoring. Stroke 2000;31:610-614. (Pubitemid 30131644)
20. Yang GY, Betz AL: Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994;25:1658-1664, discussion 1664-11655
21. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW: Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007;38:2275-2278. (Pubitemid 47457568)
22. Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, Sohn CH, Kwon SU, Suh DC, Kim SJ, Bae HJ, Kang DW: Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke: a preliminary report. Cerebrovasc Dis 2008;25:572-579.
23. Barber PA, Demchuk AM, Zhang J, Buchan AM: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Programme early CT score. Lancet 2000;355:1670-1674.
24. Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP: Using the baseline CT scan to select acute stroke patients for IVIA therapy. AJNR Am J Neuroradiol 2006;27:1612-1616.
25. Parsons MW, Pepper EM, Chan V, Siddique S, Rajaratnam S, Bateman GA, Levi CR: Perfusion computed tomography: Prediction of final infarct extent and stroke outcome. Ann Neurol 2005;58:672-679. (Pubitemid 41552542)
26. Kane I, Sandercock P, Wardlaw J: Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-491. (Pubitemid 46662896)
27. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003;34:695-698. (Pubitemid 36307395)